BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 35939435)

  • 1. SARS-CoV-2-positive patients display considerable differences in proteome diversity in urine, nasopharyngeal, gargle solution and bronchoalveolar lavage fluid samples.
    Okendo J; Musanabaganwa C; Mwangi P; Nyaga M; Onywera H
    PLoS One; 2022; 17(8):e0271870. PubMed ID: 35939435
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteomic characteristics of bronchoalveolar lavage fluid in critical COVID-19 patients.
    Zeng HL; Chen D; Yan J; Yang Q; Han QQ; Li SS; Cheng L
    FEBS J; 2021 Sep; 288(17):5190-5200. PubMed ID: 33098359
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SARS-CoV-2 diagnostics in the virology laboratory of a University Hospital in Rome during the lockdown period.
    Turriziani O; Sciandra I; Mazzuti L; Di Carlo D; Bitossi C; Calabretto M; Guerrizio G; Oliveto G; Riveros Cabral RJ; Viscido A; Falasca F; Gentile M; Pietropaolo V; Rodio DM; Carattoli A; Antonelli G
    J Med Virol; 2021 Feb; 93(2):886-891. PubMed ID: 32697357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gargle lavage as a viable alternative to swab for detection of SARS-CoV-2.
    Mittal A; Gupta A; Kumar S; Surjit M; Singh B; Soneja M; Soni KD; Khan AR; Singh K; Naik S; Kumar A; Aggarwal R; Nischal N; Sinha S; Trikha A; Wig N
    Indian J Med Res; 2020 Jul & Aug; 152(1 & 2):77-81. PubMed ID: 32820725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simple concentration method enables the use of gargle and mouthwash instead of nasopharyngeal swab sampling for the diagnosis of COVID-19 by PCR.
    Kocagoz T; Can O; Yurttutan Uyar N; Aksoy E; Polat T; Cankaya D; Karakus B; Mozioglu E; Kocagoz S
    Eur J Clin Microbiol Infect Dis; 2021 Dec; 40(12):2617-2622. PubMed ID: 34448088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gargle lavage & saliva: Feasible & cheaper alternatives to nasal & throat swabs for diagnosis of COVID-19.
    Gupta A; Mittal A; Dhakad S; Brijwal M; Soneja M; Srigyan D; Xess A; Kumar A; Ray A; Meena VP; Garg RK; Singh K; Desai D; Chowdhury M; Chowdhury S; Sharma K; Narayan A; Krishnan GR; Naik S; Dar L; Pandey RM; Pandey S; Sinha S; Wig N
    Indian J Med Res; 2021 May; 153(5&6):665-670. PubMed ID: 34414924
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DIA-Based Proteome Profiling of Nasopharyngeal Swabs from COVID-19 Patients.
    Mun DG; Vanderboom PM; Madugundu AK; Garapati K; Chavan S; Peterson JA; Saraswat M; Pandey A
    J Proteome Res; 2021 Aug; 20(8):4165-4175. PubMed ID: 34292740
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma proteomic signature predicts who will get persistent symptoms following SARS-CoV-2 infection.
    Captur G; Moon JC; Topriceanu CC; Joy G; Swadling L; Hallqvist J; Doykov I; Patel N; Spiewak J; Baldwin T; Hamblin M; Menacho K; Fontana M; Treibel TA; Manisty C; O'Brien B; Gibbons JM; Pade C; Brooks T; Altmann DM; Boyton RJ; McKnight Á; Maini MK; Noursadeghi M; Mills K; Heywood WE;
    EBioMedicine; 2022 Nov; 85():104293. PubMed ID: 36182629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.
    Emadi A; Chua JV; Talwani R; Bentzen SM; Baddley J
    Trials; 2020 Oct; 21(1):897. PubMed ID: 33115543
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection profile of SARS-CoV-2 using RT-PCR in different types of clinical specimens: A systematic review and meta-analysis.
    Bwire GM; Majigo MV; Njiro BJ; Mawazo A
    J Med Virol; 2021 Feb; 93(2):719-725. PubMed ID: 32706393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The novel coronavirus (COVID-19) pneumonia with negative detection of viral ribonucleic acid from nasopharyngeal swabs: a case report.
    Zhang P; Cai Z; Wu W; Peng L; Li Y; Chen C; Chen L; Li J; Cao M; Feng S; Jiang X; Yuan J; Liu Y; Yang L; Wang F
    BMC Infect Dis; 2020 Apr; 20(1):317. PubMed ID: 32354369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) in outpatients: A multicenter comparison of self-collected saline gargle, oral swab, and combined oral-anterior nasal swab to a provider collected nasopharyngeal swab.
    Kandel CE; Young M; Serbanescu MA; Powis JE; Bulir D; Callahan J; Katz K; McCready J; Racher H; Sheldrake E; Quon D; Vojdani OK; McGeer A; Goneau LW; Vermeiren C
    Infect Control Hosp Epidemiol; 2021 Nov; 42(11):1340-1344. PubMed ID: 33436122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-Collected Saline Gargle Samples as an Alternative to Health Care Worker-Collected Nasopharyngeal Swabs for COVID-19 Diagnosis in Outpatients.
    Goldfarb DM; Tilley P; Al-Rawahi GN; Srigley JA; Ford G; Pedersen H; Pabbi A; Hannam-Clark S; Charles M; Dittrick M; Gadkar VJ; Pernica JM; Hoang LMN
    J Clin Microbiol; 2021 Mar; 59(4):. PubMed ID: 33514627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 Detection on Bronchoalveolar Lavage: An Italian Multicenter experience.
    Patrucco F; Albera C; Bellocchia M; Foci V; Gavelli F; Castello LM; Bellan M; Sainaghi PP; Airoldi C; Balbo PE; Solidoro P
    Respiration; 2020; 99(11):970-978. PubMed ID: 33075793
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mass Spectrometric Identification of SARS-CoV-2 Proteins from Gargle Solution Samples of COVID-19 Patients.
    Ihling C; Tänzler D; Hagemann S; Kehlen A; Hüttelmaier S; Arlt C; Sinz A
    J Proteome Res; 2020 Nov; 19(11):4389-4392. PubMed ID: 32568543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteo-Genomic Analysis of SARS-CoV-2: A Clinical Landscape of Single-Nucleotide Polymorphisms, COVID-19 Proteome, and Host Responses.
    Tushir S; Kamanna S; Nath SS; Bhat A; Rose S; Aithal AR; Tatu U
    J Proteome Res; 2021 Mar; 20(3):1591-1601. PubMed ID: 33555895
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A quadruple blind, randomised controlled trial of gargling agents in reducing intraoral viral load among hospitalised COVID-19 patients: A structured summary of a study protocol for a randomised controlled trial.
    Khan FR; Kazmi SMR; Iqbal NT; Iqbal J; Ali ST; Abbas SA
    Trials; 2020 Sep; 21(1):785. PubMed ID: 32928313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Upregulation of Human Endogenous Retroviruses in Bronchoalveolar Lavage Fluid of COVID-19 Patients.
    Kitsou K; Kotanidou A; Paraskevis D; Karamitros T; Katzourakis A; Tedder R; Hurst T; Sapounas S; Kotsinas A; Gorgoulis V; Spoulou V; Tsiodras S; Lagiou P; Magiorkinis G
    Microbiol Spectr; 2021 Oct; 9(2):e0126021. PubMed ID: 34612698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ubiquitin-Modified Proteome of SARS-CoV-2-Infected Host Cells Reveals Insights into Virus-Host Interaction and Pathogenesis.
    Zhang H; Zheng H; Zhu J; Dong Q; Wang J; Fan H; Chen Y; Zhang X; Han X; Li Q; Lu J; Tong Y; Chen Z
    J Proteome Res; 2021 May; 20(5):2224-2239. PubMed ID: 33666082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.